Search Results - "Norma, Deri"
-
1
Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS
Published in PloS one (05-06-2015)“…Multiple Sclerosis is more common in women than men and females have more relapses than men. In a large international cohort we have evaluated the effect of…”
Get full text
Journal Article -
2
Risk of secondary progressive multiple sclerosis: A longitudinal study
Published in Multiple sclerosis (01-01-2020)“…Background: The risk factors for conversion from relapsing-remitting to secondary progressive multiple sclerosis remain highly contested. Objective: The aim of…”
Get full text
Journal Article -
3
Diagnostic uncertainty during the transition to secondary progressive multiple sclerosis: Multicenter study in Argentina
Published in Multiple sclerosis (01-04-2021)“…Background: A period of diagnostic uncertainty often characterizes the clinical transition from relapsing to secondary progressive multiple sclerosis (SPMS)…”
Get full text
Journal Article -
4
Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world setting
Published in Multiple sclerosis (01-09-2023)“…Background: We aimed to assess the frequency of new asymptomatic lesions on brain and spinal imaging (magnetic resonance imaging (MRI)) and their association…”
Get full text
Journal Article -
5
Clinical and demographic characteristics of primary progressive multiple sclerosis in Argentina: Argentinean registry cohort study (RelevarEM)
Published in Neurological sciences (01-11-2020)“…Background Primary progressive multiple sclerosis (PPMS) is an infrequent clinical form of multiple sclerosis (MS). Scarce information is available about PPMS…”
Get full text
Journal Article -
6
Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS
Published in Neurology (05-09-2017)“…OBJECTIVE:To investigate the effect of disease-modifying treatment on short-term disability outcomes in secondary progressive multiple sclerosis (SPMS)…”
Get full text
Journal Article -
7
Comparative effectiveness in multiple sclerosis: A methodological comparison
Published in Multiple sclerosis (01-03-2023)“…Background: In the absence of evidence from randomised controlled trials, observational data can be used to emulate clinical trials and guide clinical…”
Get full text
Journal Article -
8
Do immunosuppressive treatments influence immune responses against adenovirus-based COVID-19 vaccines in patients with multiple sclerosis? An Argentine multicenter study
Published in Frontiers in immunology (19-08-2024)“…There are no reports in LATAM related to longitudinal humoral and cellular response to adenovirus based COVID-19 vaccines in people with Multiple Sclerosis…”
Get full text
Journal Article -
9
Multiple sclerosis and neuromyelitis optica spectrum disorders in Argentina: comparing baseline data from the Argentinean MS Registry (RelevarEM)
Published in Neurological sciences (01-06-2020)“…The objective of this study was to describe and compare the baseline epidemiological data of multiple sclerosis (MS) and neuromyelitis optica spectrum disorder…”
Get full text
Journal Article -
10
-
11
Assessing attacks and treatment response rates among adult patients with NMOSD and MOGAD: Data from a nationwide registry in Argentina
Published in Multiple sclerosis journal - experimental, translational and clinical (01-07-2021)“…We aimed to examine treatment interventions implemented in patients experiencing neuromyelitis optica spectrum disorders (NMOSD) attacks (frequency, types, and…”
Get full text
Journal Article -
12
Mortality of neuromyelitis optica spectrum disorder patients in an Argentinean population: A study from the RelevarEM registry
Published in Multiple sclerosis journal - experimental, translational and clinical (01-10-2023)“…We aimed to evaluate mortality and causes of death among Argentinean neuromyelitis optica spectrum disorder (NMOSD) patients and identify predictors of death…”
Get full text
Journal Article -
13
Machine-learning-based prediction of disability progression in multiple sclerosis: An observational, international, multi-center study
Published in PLOS digital health (01-07-2024)“…Disability progression is a key milestone in the disease evolution of people with multiple sclerosis (PwMS). Prediction models of the probability of disability…”
Get full text
Journal Article -
14
Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis
Published in PloS one (21-05-2013)“…To compare treatment persistence between two dosages of interferon β-1a in a large observational multiple sclerosis registry and assess disease outcomes of…”
Get full text
Journal Article -
15
Achieving no evidence of disease activity-3 in highly active multiple sclerosis patients treated with cladribine and monoclonal antibodies
Published in Multiple sclerosis journal - experimental, translational and clinical (01-01-2023)“…Background We aimed to determine the proportion of highly active multiple sclerosis patients under high-efficacy therapies (HETs) achieve no evidence of…”
Get full text
Journal Article -
16
Family planning in Argentinian women with multiple sclerosis: An important yet seldom approached issue
Published in Multiple sclerosis journal - experimental, translational and clinical (01-04-2021)“…Background The purpose of this study was to assess family planning (FP) among women with multiple sclerosis (WwMS). Methods We invited 604 WwMS to answer a…”
Get full text
Journal Article -
17
ENCOMS: Argentinian survey in cost of illness and unmet needs in multiple sclerosis
Published in Arquivos de neuro-psiquiatria (01-05-2014)“…The objective of the study was to assess the cost of multiple sclerosis (MS) patients in Argentina categorized by disease severity using a societal…”
Get full text
Journal Article -
18
COVID-19 in multiple sclerosis and neuromyelitis optica spectrum disorder patients in Latin America
Published in Multiple sclerosis and related disorders (01-06-2021)“…•RELACOEM is the first study conducted in LATAM evaluating risk of COVID-19 in patients with MS and NMOSD•We found an increased proportion of hospitalizations…”
Get full text
Journal Article -
19
Multiple sclerosis in Latin America: A different disease course severity? A collaborative study from the MSBase Registry
Published in Multiple sclerosis journal - experimental, translational and clinical (14-08-2015)“…Limited data suggest that multiple sclerosis (MS) in Latin America (LA) could be less severe than in the rest of the world. The objective was to compare the…”
Get full text
Journal Article -
20
Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis
Published in JAMA neurology (01-07-2023)“…Autologous hematopoietic stem cell transplant (AHSCT) is available for treatment of highly active multiple sclerosis (MS). To compare the effectiveness of…”
Get more information
Journal Article